Folefac Aminkeng

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Venues

Cancers

Clinical pharmacology and therapeutics

PloS one

National University of Singapore

Vrije Universiteit Brussel (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National University of Singapore Apr 02 2020

Singapore

Assistant Professor :: . Department of Medicine, Yong Loo Lin School of Medicine

National University Health System Apr 02 2020

Singapore

Faculty :: Centre for Personalized and Precision Health

National University of Singapore Jul 01 2018 - Dec 31 2019

Singapore

Adjunct Assistant Professor :: Department of Pharmacology, Yong Loo Lin School of Medicine

National University of Singapore Jan 01 2018 - Dec 31 2019

Singapore

Adjunct Assistant Professor :: . Department of Medicine, Yong Loo Lin School of Medicine

Agency for Science, Technology and Research Feb 05 2017 - Dec 31 2019

Singapore

Assistant Principal Investigator :: Translational Laboratory in Genetic Medicine Singapore, academic/medres

Agency for Science, Technology and Research Feb 05 2017 - Dec 31 2019

Singapore

Head - Pharmacogenomics and Personalized Medicine Program :: Translational Laboratory in Genetic Medicine Singapore, academic/medres

University of British Columbia Apr 01 2016 - Jan 31 2017

Canada

Research Associate :: Medical Genetics

University of British Columbia Feb 07 2011 - Mar 31 2016

Canada

Postdoctoral Fellow :: Medical Genetics

University of Ottawa Dec 06 2010 - Feb 06 2011

Canada

Postdoctoral Fellow :: Health Sciences

Education History

Vrije Universiteit Brussel Sep 01 2005 - Sep 07 2010

Belgium

PHD :: Medical Biochemistry and Diabetes Research Centre

Vrije Universiteit Brussel Sep 01 2003 - Jun 30 2005

Belgium

MSC :: Medical Biochemsitry and Diabetes Research Centre

University of Buea Jan 09 1997 - Aug 31 2001

Cameroon

BSC :: Medical Laboratory Science

Publications

Akinyemi Oni-Orisan, Sony Tuteja, Glenda Hoffecker, D Max Smith, Matteo Castrichini, Kristine R Crews, William A Murphy, Nam H K Nguyen, Yimei Huang, Christelle Lteif, Kevin A Friede, Kelan Tantisira, Folefac Aminkeng, Deepak Voora, Larisa H Cavallari, Michelle Whirl-Carrillo, Julio D Duarte, Jasmine A Luzum, null null
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers. Clinical pharmacology and therapeutics (2023)
Soo-Chin Lee, Joseph J Zhao, Yu Yang Soon, Adrian Kee, Sen Hee Tay, Folefac Aminkeng, Yvonne Ang, Alvin S C Wong, Lavina D Bharwani, Boon Cher Goh, Ross A Soo
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer. Cancers 15 (10) (2023)
Pei Yi Lee, Kellynn Qi Xuan Oen, Grace Rui Si Lim, Juanda Leo Hartono, Mark Dhinesh Muthiah, Daniel Q Huang, Felicia Su Wei Teo, Andrew Yunkai Li, Anselm Mak, Nisha Suyien Chandran, Chris Lixian Tan, Peiling Yang, E Shyong Tai, Kay Wei Ping Ng, Joy Vijayan, Yee Cheun Chan, Li Ling Tan, Martin Beng-Huat Lee, Horng Ruey Chua, Wei Zhen Hong, Eng Soo Yap, Dawn K Lim, Yew Sen Yuen, Yiong-Huak Chan, Folefac Aminkeng, Alvin Seng Cheong Wong, Yiqing Huang, Sen Hee Tay
Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study. Cancers 13 (6) (2021)
Sze Ling Chan, Angeline Poh Gek Chua, Folefac Aminkeng, Cynthia Bin Eng Chee, Shengnan Jin, Marie Loh, Suay Hong Gan, Yee Tang Wang, Liam R Brunham
Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients. PloS one 12 (10) (2017)

Folefac Aminkeng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Folefac Aminkeng